MUC4/HER2 is a pro-oncogenic complex involved in cancer cell tumorigenic properties and in activation of different oncogenic signaling pathways leading to tumor progression in many epithelial cancers (lung, esophagus, colon, breast, and pancreas) [1,3,9,10]. This evidence concerns the gene ERBB2 and cancer.